#148 - Psychedelics for Mental Health

Matt delves into how psychedelics like psilocybin and LSD quiet the "Default Mode Network" to boost neuroplasticity. He describes these molecules as a "crowbar" that allows therapy to break deep-seated patterns of depression and reorganize the mind.

Matt also reviews MDMA and ketamine trials for PTSD and trauma. While noting the brain's capacity for rapid change, he addresses research risks like the "blinding problem" and debunks microdosing myths. In essence, today’s episode presents a balanced look at this evolving psychiatric frontier.

Please note that Matt is not a medical doctor, and none of the content in this podcast should be considered medical advice in any way, shape, or form, nor prescriptive in any way.

In a supplement industry where trust is critical, Matt uses podcast supporter Puori. Their protein powders are free from hormones, GMOs, and pesticides, with every single batch third-party tested for over 200 contaminants. For protein you can trust, save 20% at puori.com/mattwalker.

Matt uses podcast sponsor Square for a reason: it's seamless, fast, and smart. From Apple Pay to real-time tracking, Square makes getting paid the easiest part of business. No hidden fees or contracts, just tools that scale with you. Get up to $200 off hardware at square.com/go/mattwalker.

As always, if you have thoughts or feedback you’d like to share, please reach out to Matt:

Matt: Instagram @drmattwalker, X @sleepdiplomat,

YouTube: https://www.youtube.com/@sleepdiplomat